Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
5
×
boston blog main
national blog main
biotech
national top stories
new york blog main
new york top stories
san francisco blog main
boston
boston top stories
clinical trials
digital health
fda
pfizer
san diego blog main
san diego top stories
san francisco top stories
startups
akcea therapeutics
akero therapeutics
akili interactive labs
alnylam pharmaceuticals
andrew fire
antidepressant
apellis pharmaceuticals
aragon pharmaceuticals
assurex health
biologic drugs
boston xcon
boulder/denver blog main
boulder/denver top stories
boulder/denver xcon
brca-1
brca-2
bruce leuchter
bryan dechairo
charles debattista
click therapeutics
clickotine
clinical trial
What
making
5
×
medicine
5
×
drug
medicines
new
afternoon
alnylam
alnylam’s
announced
approach
approved
backs
bags
bets
biologic
biotechs
bottleneck
cancer
capital
centers
click
clinical
cut
depression
development
digital
dramatically
event
example
fda
field
fixing
gain
genetic
genomic
gets
grabbed
guesswork
guide
helps
Language
unset
Current search:
making
×
medicine
×
" life sciences "
×
@xconomy.com
4 years ago
VenBio Partners Bags $394M to Back More Medicine-Making Biotechs
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug
@xconomy.com
5 years ago
Sanofi Backs Click Therapeutics as Digital Medicines Gain Momentum
@xconomy.com
5 years ago
Fixing the Clinical Trial Bottleneck by Making Patients a Priority
@xconomy.com
5 years ago
Will New Study Cut Guesswork for Depression Medicine Prescriptions?
